-
The ASAM Weekly for January 14th, 2025
Review of Evidence on Alcohol and HealthFull story
Recent and Past Issues
-
The ASAM Weekly for March 5th, 2024
Racial and Ethnic Disparities in Geographic Availability of BuprenorphineFull story -
The ASAM Weekly for February 27, 2024
Are Headlines, Crises, and the Innocence of Youth Distracting Us from the Realities of Addiction Later in Life?Full story -
Guest Editorial: Are Headlines, Crises, and the Innocence of Youth Distracting Us from the Realities of Addiction Later in Life?
The question was simple: Do people still smoke cigarettes? They asked because none of their friends or family smoked, they didn’t see people do it in public, and they hadn’t seen a cigarette butt since the 90s.Full story -
The ASAM Weekly for February 20, 2024
Overdose mortality incidence and supervised consumption servicesFull story -
The ASAM Weekly for February 13, 2024
Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancyFull story -
The ASAM Weekly for February 6, 2024
Bringing Racial Justice to US Drug Policy Promotes Equity and Access to Addiction TreatmentFull story -
Guest Editorial: Bringing Racial Justice to US Drug Policy Promotes Equity and Access to Addiction Treatment
Right now in the US, a Black man is living with the disease of addiction after being released from prison for possession of cocaine (for which there has long been a racist sentencing disparity between its rock and powder forms). Chances are, he did not receive evidence-based addiction treatment while incarcerated. Furthermore, notwithstanding the physical and emotional trauma he likely endured while in prison, he returns to the community without any resources to secure housing, health care, or employment.Full story -
The ASAM Weekly for January 30, 2024
First Trimester Use of Buprenorphine or Methadone.Full story -
The ASAM Weekly for January 23, 2024
History Repeats Itself - Trends in hallucinogen-associated emergency department visits and hospitalizations.Full story -
Guest Editorial: History Repeats Itself: Psychedelics Are Promoted Today the Way Opioids Were Promoted in the Early 2000s
After more than two decades as a practicing psychiatrist, I’ll be the first to admit that we need new and innovative treatments to treat depression, anxiety, and other psychiatric disorders. Psychedelics like LSD, psilocybin, and MDMA (Ecstasy) are being researched and promoted as ground-breaking advances for combatting mental illness. Multiple jurisdictions have already relaxed laws or policies related to these substances, often with an eye toward therapeutic use.Full story
This Week in Addiction Medicine Podcast
A weekly audio summary and podcast of the ASAM Weekly
The ASAM Weekly
Editors & Staff
Editor-in-Chief: Nicholas Athanasiou, MD, MBA, DFASAM
Emeritus Editor: William Haning, MD, DFAPA, DFASAM
Publications Chair: Nicholas Athanasiou, MD, MBA, DFASAM
Co-Editors: Brandon
Aden, MD, Jack Woodside, MD, John A. Fromson, MD
Please direct customer service inquiries and comments to: ASAMWeekly@ASAM.org
The ASAM Weekly
Advertiser Services & Sales
Ad space is limited and available on a first-paid, first-published basis. To assure your ad will run in the specific issue you select, Insertion Orders must be signed by an authorized person in your organization and accepted by your customer service representative before taking the advertising units out of the active sales inventory. Payment must be received prior to the run date for an ad. Insertion Orders provide several options for payment in full including all major credit cards or check. Pre-approved billing must be arranged directly by an ASAM representative.
To learn more about advertising opportunities
Contact: Claire Rasmussen <crasmussen@asam.org>